95 related articles for article (PubMed ID: 24521996)
1. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
Martino A; Campa D; Jurczyszyn A; Martínez-López J; Moreno MJ; Varkonyi J; Dumontet C; García-Sanz R; Gemignani F; Jamroziak K; Stępieł A; Jacobsen SE; Andersen V; Jurado M; Landi S; Rossi AM; Lesueur F; Marques H; Dudziński M; Wątek M; Moreno V; Orciuolo E; Petrini M; Reis RM; Ríos R; Sainz J; Vogel U; Buda G; Vangsted AJ; Canzian F
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):670-4. PubMed ID: 24521996
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.
Martino A; Sainz J; Manuel Reis R; Moreno V; Buda G; Lesueur F; Marques H; García-Sanz R; Ríos R; Stein A; Dumontet C; Gemignani F; Maria Rossi A; Landi S; Jurado M; Petrini M; Jamroziak K; Campa D; Canzian F
J Hum Genet; 2013 Mar; 58(3):155-9. PubMed ID: 23303387
[TBL] [Abstract][Full Text] [Related]
3. Identification of miRSNPs associated with the risk of multiple myeloma.
Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
[TBL] [Abstract][Full Text] [Related]
4. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).
Martino A; Sainz J; Buda G; Jamroziak K; Reis RM; García-Sanz R; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Lesueur F; Moreno V; Orciuolo E; Gemignani F; Landi S; Rossi AM; Dumontet C; Petrini M; Campa D; Canzian F
Int J Oncol; 2012 Mar; 40(3):625-38. PubMed ID: 22159523
[TBL] [Abstract][Full Text] [Related]
5. Variation in innate immunity genes and risk of multiple myeloma.
Purdue MP; Lan Q; Menashe I; Zheng T; Zhang Y; Yeager M; Hosgood HD; Zahm SH; Chanock SJ; Rothman N; Baris D
Hematol Oncol; 2011 Mar; 29(1):42-6. PubMed ID: 20658475
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
Ríos R; Lupiañez CB; Campa D; Martino A; Martínez-López J; Martínez-Bueno M; Varkonyi J; García-Sanz R; Jamroziak K; Dumontet C; Cayuela AJ; Wętek M; Landi S; Rossi AM; Lesueur F; Reis RM; Moreno V; Marques H; Jurczyszyn A; Andersen V; Vogel U; Buda G; Orciuolo E; Jacobsen SE; Petrini M; Vangsted AJ; Gemignani F; Canzian F; Jurado M; Sainz J
Endocr Relat Cancer; 2015 Aug; 22(4):545-59. PubMed ID: 26099684
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
Lincz LF; Scorgie FE; Robertson R; Enno A
Leuk Res; 2007 Jun; 31(6):759-63. PubMed ID: 16949155
[TBL] [Abstract][Full Text] [Related]
8. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study.
Mfuna Endam L; Cormier C; Bossé Y; Filali-Mouhim A; Desrosiers M
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):187-92. PubMed ID: 20157068
[TBL] [Abstract][Full Text] [Related]
9. Role of vitamin D receptor (VDR) polymorphisms in susceptibility to multiple myeloma in ethnic Kashmiri population.
Shafia S; Qasim I; Aziz SA; Bhat IA; Nisar S; Shah ZA
Blood Cells Mol Dis; 2013 Jun; 51(1):56-60. PubMed ID: 23453529
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk.
Maggini V; Buda G; Galimberti S; Martino A; Orciuolo E; Morabito F; Bono R; Barale R; Petrini M; Rossi AM
Leuk Res; 2008 Jun; 32(6):988-90. PubMed ID: 18061666
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma.
Kim HN; Kim YK; Lee IK; Lee JJ; Yang DH; Park KS; Choi JS; Park MR; Jo DY; Kim HJ
Am J Hematol; 2007 Sep; 82(9):798-801. PubMed ID: 17546637
[TBL] [Abstract][Full Text] [Related]
12. Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?
Martino A; Buda G; Maggini V; Lapi F; Lupia A; Di Bello D; Orciuolo E; Galimberti S; Barale R; Petrini M; Rossi AM
Leuk Res; 2012 May; 36(5):594-7. PubMed ID: 22387051
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Campa D; Martino A; Sainz J; Buda G; Jamroziak K; Weinhold N; Vieira Reis RM; García-Sanz R; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Lesueur F; Bugert P; Moreno V; Szemraj J; Orciuolo E; Gemignani F; Rossi AM; Dumontet C; Petrini M; Goldschmidt H; Landi S; Canzian F
Br J Haematol; 2012 May; 157(3):331-8. PubMed ID: 22590720
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk.
Hosgood HD; Baris D; Zhang Y; Berndt SI; Menashe I; Morton LM; Lee KM; Yeager M; Zahm SH; Chanock S; Zheng T; Lan Q
Leuk Res; 2009 Dec; 33(12):1609-14. PubMed ID: 19362737
[TBL] [Abstract][Full Text] [Related]
16. Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma.
Chiusolo P; Farina G; Putzulu R; Reddiconto G; Fiorini A; De Stefano V; Rossi E; Palladino M; Leone G; Sica S
Ann Hematol; 2006 Jul; 85(7):474-7. PubMed ID: 16541270
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and multiple myeloma risk: a meta-analysis.
Zhang P; Liu B
Ann Hematol; 2020 May; 99(5):1017-1024. PubMed ID: 32162036
[TBL] [Abstract][Full Text] [Related]
18. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.
Ríos-Tamayo R; Lupiañez CB; Campa D; Hielscher T; Weinhold N; Martínez-López J; Jerez A; Landi S; Jamroziak K; Dumontet C; Wątek M; Lesueur F; Reis RM; Marques H; Jurczyszyn A; Vogel U; Buda G; García-Sanz R; Orciuolo E; Petrini M; Vangsted AJ; Gemignani F; Försti A; Goldschmidt H; Hemminki K; Canzian F; Jurado M; Sainz J
Oncotarget; 2016 Sep; 7(37):59029-59048. PubMed ID: 27437873
[TBL] [Abstract][Full Text] [Related]
19. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
[TBL] [Abstract][Full Text] [Related]
20. Haplotypes in the tumour necrosis factor region and myeloma.
Morgan GJ; Adamson PJ; Mensah FK; Spink CF; Law GR; Keen LJ; Roman E; Davies FE; Rollinson S; Child JA; Bidwell JL
Br J Haematol; 2005 May; 129(3):358-65. PubMed ID: 15842659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
